{"id":21051,"date":"2023-02-03T15:41:46","date_gmt":"2023-02-03T10:11:46","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=21051"},"modified":"2023-05-22T12:17:03","modified_gmt":"2023-05-22T06:47:03","slug":"androgenetic-alopecia-treatment-outlook","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook","title":{"rendered":"Millions of Patients and Billions in Untapped Androgenetic Alopecia Treatment Market"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a0e2a78151fd\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a0e2a78151fd\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\/#Social_Stigma_Related_to_Androgenetic_Alopecia\" >Social Stigma Related to Androgenetic Alopecia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\/#Minoxidil_Ruling_the_Androgenetic_Alopecia_Treatment_Market\" >Minoxidil Ruling the Androgenetic Alopecia Treatment Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\/#Expected_Roadblocks_in_the_Androgenetic_Alopecia_Treatment_Market\" >Expected Roadblocks in the Androgenetic Alopecia Treatment Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\/#Optimistic_Future_of_the_Androgenetic_Alopecia_Treatment_Market\" >Optimistic Future of the Androgenetic Alopecia Treatment Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Androgenetic alopecia is a genetic disorder caused by an overreaction to androgens. This condition affects up to <strong>50%<\/strong> of males and females and is characterized by progressive loss of terminal hair on the scalp at any time after puberty. As per Asadi (2020), androgenetic alopecia is the common cause of hair loss in men and women.&nbsp;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>As per the DelveInsight assessment, the total number of <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-epidemiology-forecast\"><strong>prevalent cases of androgenetic alopecia<\/strong><\/a><strong> was more than 194 million in the 7MM in 2021. The highest number of cases was seen in EU4 and the UK. Assessments showed that it affected about 50 million men and 30 million women in the United States; it begins in early adolescence and progresses with age. Additionally, more than 50% of men over 50 experience hair loss, whereas, in women, hair loss is more likely to occur after menopause.<\/strong><\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-social-stigma-related-to-androgenetic-alopecia\"><span class=\"ez-toc-section\" id=\"Social_Stigma_Related_to_Androgenetic_Alopecia\"><\/span><strong>Social Stigma Related to Androgenetic Alopecia<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In today\u2019s world, hair plays a big role in how one perceives oneself; therefore, hair loss causes various problems, including poor self-image, diminished confidence, failed relationships in marriage and love, and potential health effects. Studies show that androgenetic alopecia can worsen QoL by contributing to psychological issues such as trauma, anxiety, and depression. Previous studies showed that people with androgenetic alopecia had a much greater prevalence of personality disorders than the general population.&nbsp;<\/p>\n\n\n\n<p>Females face a ton of strain to adjust to pictures utilized by the media and marketing organizations. Be that as it may, the equivalent has likewise become valid for men throughout recent years. Images of actual flawlessness seldom show a man who has lost or is losing his hair.<\/p>\n\n\n\n<p>Looking at oneself too brutally against these unrealistic images causes one to lose certainty and confidence. Having the \u2018sculpted physique\u2019 or look comes down on men to conform. Although there are endless male celebrities with bald heads, individuals consider hair loss an issue instead of acknowledging it as a natural process. Additionally, it has been noted that men exhibit more psychopathologic symptoms or a higher prevalence of personality disorders than women.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Minoxidil_Ruling_the_Androgenetic_Alopecia_Treatment_Market\"><\/span><strong>Minoxidil Ruling the Androgenetic Alopecia Treatment Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The current androgenetic alopecia treatment regimen mostly consists of oral finasteride, topical external minoxidil usage, low-intensity laser therapy, and hair transplantation. The 5-reductase inhibitor finasteride has a considerable impact on the androgenetic alopecia treatment, but it can also cause unfavorable side effects in a small percentage of patients. Sometimes, adverse androgenetic alopecia symptoms like post-finasteride syndrome continue even after medication is stopped.<\/p>\n\n\n\n<p><strong>Finasteride<\/strong> is approved in males with androgenetic alopecia due to the side effects associated with finasteride; it is generally not recommended for females. Moreover, the risk of a male embryo developing hypospadias should prevent pregnant women from consuming or handling crushed finasteride tablets.<\/p>\n\n\n\n<p>Another drug used for the androgenetic alopecia treatment is <strong>dutasteride<\/strong>. It frequently causes erectile dysfunction, decreased semen production, and decreased sex drive as side effects. The drug is possibly more successful than finasteride for treating hair loss, but it also experiences similar rates and adverse effects.<\/p>\n\n\n\n<p>Owing to the side effects of finasteride and other <a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-pipeline-insight\">androgenetic alopecia drugs<\/a>, topical <strong>minoxidil <\/strong>is preferred as it does not require a prescription. <strong>Minoxidil <\/strong>promotes hair growth by enlarging miniaturized hair follicles, extending anagen, and shortening telogen through an unknown mechanism. In the United States, topical minoxidil is available over the counter in <strong>2% and 5%<\/strong> solutions, as well as <strong>5%<\/strong> foam. When dry, patients should apply 1 mL of <strong>5%<\/strong> solution or half a cap of <strong>5%<\/strong> foam to affected areas of the scalp (not the hair). Treatment efficacy should be evaluated after one year of use, but results may be seen sooner.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment-1024x398.png\" alt=\"Androgenetic Alopecia Market Assessment\" class=\"wp-image-21058\" width=\"1024\" height=\"398\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment-1024x398.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment-300x117.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment-150x58.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment-768x299.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115725\/Androgenetic-Alopecia-Market-Assessment.png 1378w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\"><strong>Androgenetic Alopecia Market Assessment<\/strong><\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Expected_Roadblocks_in_the_Androgenetic_Alopecia_Treatment_Market\"><\/span><strong>Expected Roadblocks in the Androgenetic Alopecia Treatment Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Although androgens have been identified as the cause of androgenetic alopecia, the etiology and pathogenesis of both male and female pattern hair loss remain unknown. Furthermore, the relationship between androgens and hair loss in women is unclear. Moreover, the scarcity of new epidemiology studies and the dearth of literature on prepubertal androgenetic alopecia, differential diagnosis, and comorbidities associated with pattern hair loss point to the need for ongoing research in these areas.<\/p>\n\n\n\n<p>Furthermore, the widespread use of <a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-market\">off-label androgenetic alopecia therapies<\/a> for the treatment of male and female pattern hair loss, such as dutasteride, prostaglandin analogs, and polyphenols, poses a significant threat to emerging candidates in the androgenetic alopecia treatment space. Moreover, androgenetic alopecia treatment can be especially difficult due to non-uniformity in patient response to conventional therapies, which causes patient non-adherence because they must continue the therapy due to disease relapse after androgenetic alopecia treatment discontinuation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Optimistic_Future_of_the_Androgenetic_Alopecia_Treatment_Market\"><\/span><strong>Optimistic Future of the Androgenetic Alopecia Treatment Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>As androgenetic alopecia is not life-threatening, androgenetic alopecia treatments remain a challenge consisting of a few long-term therapies. These long-term androgenetic alopecia therapies possess several side effects and compliance issues. Moreover, discontinuing the <a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-pipeline-insight\">existing androgenetic alopecia therapies<\/a> can result in the relapse of androgenetic alopecia. Hence, research demanding long-term solutions and permanent androgenetic alopecia treatment are required.<\/p>\n\n\n\n<p>As a result, the androgenetic alopecia treatment market offers a significant opportunity for several players to capitalize on the untapped androgenetic alopecia treatment market. Although the field is quite active and trials to treat <a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-epidemiology-forecast\">patients with androgenetic alopecia<\/a> are underway, ongoing efforts are required to develop androgenetic alopecia drugs that are both more effective and less toxic. As there are only two approved pharmaceutical androgenetic alopecia treatments across the entire landscape, any significant advancement in this direction is expected to have an impact on the current androgenetic alopecia treatment market scenario during the forecast period (2022\u20132032).<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>As per Delveinsight analysis, the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-market\"><strong>androgenetic alopecia market<\/strong><\/a><strong> was valued at around USD 5,600 million in 2019 and is expected to reach USD 7,000 million in 2032, growing at a CAGR of 1.81% during the study period.&nbsp;<\/strong><\/p>\n<\/blockquote>\n\n\n\n<p>Companies such as <strong>Kintor Pharmaceutical (KX-826) <\/strong>and <strong>Cosmo Pharmaceuticals (BREEZULA)<\/strong> are investigating their respective candidates for the management of androgenetic alopecia. Several late-stage assets with distinct MoA are being developed to treat androgenetic alopecia patients and are expected to enter the 7MM androgenetic alopecia treatment market in the next few years.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/androgenetic-alopecia-market\"><img decoding=\"async\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-1024x256.png\" alt=\"androgenetic alopecia market outlook\" class=\"wp-image-21057\" width=\"1024\" height=\"256\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-1024x256.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-300x75.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-150x38.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-768x192.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-1536x384.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook-1568x392.png 1568w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115425\/androgenetic-alopecia-market-outlook.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1675404456215\"><strong class=\"schema-faq-question\"><strong>1. What is androgenetic alopecia?<\/strong><\/strong> <p class=\"schema-faq-answer\">Male and female pattern hair loss (FPHL), also known as androgenetic alopecia (AGA), is a relatively common condition that affects people from all walks of life. Although androgens are the main hormones involved in the pathophysiology of male AGA, FPHL has not always been linked to androgens.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1675404470296\"><strong class=\"schema-faq-question\"><strong>2. what causes androgenetic alopecia?<\/strong><\/strong> <p class=\"schema-faq-answer\">Androgenetic alopecia is caused by a combination of genetics and the effects of male sex hormones known as androgens. Androgenetic alopecia, in particular, is caused by a genetic sensitivity to the androgen DHT, or dihydrotestosterone.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1675404484962\"><strong class=\"schema-faq-question\"><strong>3. How is androgenetic alopecia diagnosed?\u00a0<\/strong><\/strong> <p class=\"schema-faq-answer\">Androgenetic alopecia is typically clinically diagnosed with a history of gradual onset after puberty and, often but not always, a family history of baldness. Unless the androgenetic alopecia diagnosis is unclear, a biopsy is usually not required. Dermoscopy reveals miniaturized hair and brown perihilar casts, which can help distinguish diffuse alopecia areata from male pattern baldness, as diffuse alopecia areata has tapered fractures such as exclamation point hairs.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1675404499559\"><strong class=\"schema-faq-question\"><strong>4. How to cure androgenetic alopecia?<\/strong><\/strong> <p class=\"schema-faq-answer\">The two drugs approved by the FDA for androgenetic alopecia are topical minoxidil (ROGAINE) and finasteride (PROPECIA), both of which require at least a 4-6 month trial before noticing improvement and must be used indefinitely to maintain a response. Spironolactone, dutasteride, prostaglandin analogs, laser treatments, cyproterone acetate, platelet-rich plasma, and other off-label therapies are also used to treat androgenetic alopecia. Aside from drug therapies, hair transplantation is a preferred surgical approach for androgenetic alopecia treatment.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1675404515553\"><strong class=\"schema-faq-question\"><strong>5. How common is androgenetic alopecia?<\/strong><\/strong> <p class=\"schema-faq-answer\">As per DelveInsight analysis, in 2021, the total number of prevalent cases of androgenetic alopecia was more than 194 million in the 7MM. The highest number of cases was seen in EU4 and the UK.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1675404568696\"><strong class=\"schema-faq-question\"><strong>6. How many companies are working in the androgenetic alopecia treatment market?<\/strong><\/strong> <p class=\"schema-faq-answer\">Leading companies such as Kintor Pharmaceutical, Cosmo Pharmaceuticals, Merz Aesthetics, and others are currently developing novel therapies for androgenetic alopecia treatment.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Androgenetic alopecia is a genetic disorder caused by an overreaction to androgens. This condition affects up to 50% of males and females and is characterized by progressive loss of terminal hair on the scalp at any time after puberty. As per Asadi (2020), androgenetic alopecia is the common cause of hair loss in men and [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":21054,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":5,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[17378,20321,20323,20324,20320,20322],"industry":[17225],"therapeutic_areas":[17237,17238],"class_list":["post-21051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-androgenetic-alopecia","tag-androgenetic-alopecia-drugs","tag-androgenetic-alopecia-market","tag-androgenetic-alopecia-therapies","tag-androgenetic-alopecia-treatment","tag-androgenetic-alopecia-treatment-market","industry-pharmaceutical","therapeutic_areas-dermatology","therapeutic_areas-genetic-disorders"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evolving Dynamics of Androgenetic Alopecia Treatment Market<\/title>\n<meta name=\"description\" content=\"Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolving Dynamics of Androgenetic Alopecia Treatment Market\" \/>\n<meta property=\"og:description\" content=\"Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T10:11:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-22T06:47:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook.png\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sandeep Joshi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Joshi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Evolving Dynamics of Androgenetic Alopecia Treatment Market","description":"Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook","og_locale":"en_US","og_type":"article","og_title":"Evolving Dynamics of Androgenetic Alopecia Treatment Market","og_description":"Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial","og_url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2023-02-03T10:11:46+00:00","article_modified_time":"2023-05-22T06:47:03+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook.png","type":"image\/png"}],"author":"Sandeep Joshi","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Sandeep Joshi","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook","url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook","name":"Evolving Dynamics of Androgenetic Alopecia Treatment Market","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook.png","datePublished":"2023-02-03T10:11:46+00:00","dateModified":"2023-05-22T06:47:03+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a"},"description":"Androgenetic alopecia treatment market offers a significant opportunity for several companies to investigate their lead assets. Clinical trial","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404456215"},{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404470296"},{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404484962"},{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404499559"},{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404515553"},{"@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404568696"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook.png","width":772,"height":482,"caption":"androgenetic-alopecia-treatment-outlook"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a","name":"Sandeep Joshi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","caption":"Sandeep Joshi"},"sameAs":["http:\/\/Delveinsight.com"]},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404456215","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404456215","name":"1. What is androgenetic alopecia?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Male and female pattern hair loss (FPHL), also known as androgenetic alopecia (AGA), is a relatively common condition that affects people from all walks of life. Although androgens are the main hormones involved in the pathophysiology of male AGA, FPHL has not always been linked to androgens.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404470296","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404470296","name":"2. what causes androgenetic alopecia?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Androgenetic alopecia is caused by a combination of genetics and the effects of male sex hormones known as androgens. Androgenetic alopecia, in particular, is caused by a genetic sensitivity to the androgen DHT, or dihydrotestosterone.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404484962","position":3,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404484962","name":"3. How is androgenetic alopecia diagnosed?\u00a0","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Androgenetic alopecia is typically clinically diagnosed with a history of gradual onset after puberty and, often but not always, a family history of baldness. Unless the androgenetic alopecia diagnosis is unclear, a biopsy is usually not required. Dermoscopy reveals miniaturized hair and brown perihilar casts, which can help distinguish diffuse alopecia areata from male pattern baldness, as diffuse alopecia areata has tapered fractures such as exclamation point hairs.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404499559","position":4,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404499559","name":"4. How to cure androgenetic alopecia?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The two drugs approved by the FDA for androgenetic alopecia are topical minoxidil (ROGAINE) and finasteride (PROPECIA), both of which require at least a 4-6 month trial before noticing improvement and must be used indefinitely to maintain a response. Spironolactone, dutasteride, prostaglandin analogs, laser treatments, cyproterone acetate, platelet-rich plasma, and other off-label therapies are also used to treat androgenetic alopecia. Aside from drug therapies, hair transplantation is a preferred surgical approach for androgenetic alopecia treatment.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404515553","position":5,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404515553","name":"5. How common is androgenetic alopecia?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"As per DelveInsight analysis, in 2021, the total number of prevalent cases of androgenetic alopecia was more than 194 million in the 7MM. The highest number of cases was seen in EU4 and the UK.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404568696","position":6,"url":"https:\/\/www.delveinsight.com\/blog\/androgenetic-alopecia-treatment-outlook#faq-question-1675404568696","name":"6. How many companies are working in the androgenetic alopecia treatment market?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Leading companies such as Kintor Pharmaceutical, Cosmo Pharmaceuticals, Merz Aesthetics, and others are currently developing novel therapies for androgenetic alopecia treatment.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"Sandeep Joshi","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/sjoshidelveinsight-com"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2023\/02\/03115112\/androgenetic-alopecia-treatment-outlook-300x187.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia drugs<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia therapies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia treatment<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Androgenetic Alopecia treatment market<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Androgenetic Alopecia<\/span>","<span class=\"advgb-post-tax-term\">Androgenetic Alopecia drugs<\/span>","<span class=\"advgb-post-tax-term\">Androgenetic Alopecia market<\/span>","<span class=\"advgb-post-tax-term\">Androgenetic Alopecia therapies<\/span>","<span class=\"advgb-post-tax-term\">Androgenetic Alopecia treatment<\/span>","<span class=\"advgb-post-tax-term\">Androgenetic Alopecia treatment market<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 3 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Feb 3, 2023","modified":"Updated on May 22, 2023"},"absolute_dates_time":{"created":"Posted on Feb 3, 2023 3:41 pm","modified":"Updated on May 22, 2023 12:17 pm"},"featured_img_caption":"androgenetic-alopecia-treatment-outlook","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/21051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=21051"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/21051\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/21054"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=21051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=21051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=21051"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=21051"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=21051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}